Medical Journal July 2024 Digital Edition
July 31, 20241 min
Post Views: 1,289
Closing the practice gaps: A step forward in achieving the optimal delivery of precision medicine
July 31, 202410 min
BY Susanne Munksted, Chief Precision Medicine Officer, Diaceutics, Kevin Entwistle, VP, Precision Medicine Strategy Services, Diaceutics, Helen Sadik, Precision Medicine Strategy Advisor, Diaceutics, Alasdair Milton, PhD, Principal, Healthcare and Life Sciences Strategy, KPMG In this ever-evolving healthcare landscape, precision medicine (PM) has emerged as a game changer promising to revolutionize patient care, especially cancer care. By tailoring medical treatments to each patient’s characteristics, precision medicine has the potential to lead to better outcomes while...
Lifting the veil on the 340B drug pricing program: Overview and recent developments
July 31, 20249 min
BY Michael R. Alexander, Esq. and Kianna Sitarski, Esq., Brown & Fortunato, P.C. As healthcare costs across the United States continue to rise, healthcare providers are feeling the financial squeeze associated with increasing costs of providing necessary products and services coupled with the trend of decreasing reimbursement rates paid out from patient healthcare plans. One method by which providers and healthcare systems may ease this financial burden is through participation in the 340B Drug...
Do whole body MRIs actually improve health outcomes?
July 31, 20248 min
BY Samuel Mathis, MD, MBA, Assistant Professor, UTMB Recently, I have had patients request that I order whole-body MRI (WB-MRI) evaluations for preventative services. The trend of WB-MRIs has gained some traction in Europe over the past 5 years and is becoming increasingly popular in the US. A quick internet search found 3 different companies in the greater Houston area that offer these studies with multiple new organizations opening in the next 6-12 months....
BY John Hawkins, President and CEO, THA Unbelievably – to me, at least – the second half of 2024 is upon us. We’re now less than six months from another session of the Texas Legislature that promises massive implications for hospitals and health care. And this month, our fight enters a new phase. As I told you back in January, the Texas Hospital Association is spending the year correcting the record on anti-hospital...
Memorial Hermann Appoints Mike Roussos Senior Vice President, President of Academic Hospitals and CEO, Memorial Hermann-Texas Medical Center Campus
July 31, 20244 min
Memorial Hermann Health System has announced Michael (Mike) Roussos will be joining the organization as Senior Vice President, President of Academic Hospitals and CEO, Memorial Hermann–Texas Medical Center. Recognized for his ability to drive exceptional operational, quality and financial results in academic medical centers, Mike brings more than two decades of experience as a health care executive and administrator. “We are excited to welcome Mike to Memorial Hermann in this new leadership role,”...
Memorial Hermann Appoints Jason Glover CEO of Memorial Hermann-Texas Medical Center Adult Services
July 31, 20243 min
Memorial Hermann Health System has announced Jason Glover is appointed CEO of Memorial Hermann-Texas Medical Center Adult Services. Glover brings more than a decade of health care and management experience. After joining Memorial Hermann in 2013 as an administrative fellow, Glover advanced to leadership roles at Memorial Hermann Greater Heights Hospital, Memorial Hermann Sugar Land Hospital and Memorial Hermann The Woodlands Medical Center where he served as Vice President, Operations until his January 2024...
Houston Methodist Sugar Land Hospital welcomes orthopedic spine surgeon Alexander Molinari, DO
July 31, 20242 min
Houston Methodist Orthopedics & Sports Medicine at Sugar Land Hospital is pleased to welcome spine surgeon Alexander Molinari, DO. He specializes in complex degenerative and reconstructive spine surgery including spinal deformities, revision spinal surgeries, and scoliosis. He utilizes the latest in minimally invasive techniques, navigation-assisted surgery, and disc replacements. Molinari earned his medical degree from the Arizona College of Osteopathic Medicine at Midwestern University and completed his orthopedic residency at Beaumont Health, Farmington...
MD Anderson and Summit Therapeutics announce strategic collaboration to accelerate development of ivonescimab
July 31, 20243 min
The University of Texas MD Anderson Cancer Center and Summit Therapeutics, Inc. announced a strategic five-year collaboration agreement for the purpose of accelerating the development of ivonescimab. Leveraging MD Anderson’s clinical infrastructure and research expertise together with Summit’s innovative, investigational, potential first-in-class PD-1/VEGF bispecific antibody, the collaboration is designed to quickly discover additional opportunities for ivonescimab, including several tumors outside of its current development plan. MD Anderson will lead multiple clinical trials in several tumor types to...
UTMB researchers develop nasal spray treatment for Alzheimer’s disease
July 31, 20245 min
Researchers at the University of Texas Medical Branch recently discovered a significant advancement in the fight against neurodegenerative diseases such as Alzheimer’s disease and dementia. The study introduces an innovative nasal spray treatment that has shown promising results in clearing harmful tau protein build-up and improving cognitive functions in aged mice models with neurodegenerative diseases. “This nasal spray approach opens new avenues for non-invasive delivery of tau therapeutic antibodies directly to the brain, and...